abiraterone,olaparib
janssen,merck,astrazeneca
['abira', 'abiraterone', 'propel', 'olaparib', 'prostate']
breaking from #esmo22 new 1l therapy data for metastatic castration-resistant prostate cancer: the propel phase iii trial shows abiraterone + olaparib brings superior os vs abi + placebo &amp; meaningful radiographic pfs improvement. stay tuned on #noeticinsight for all the latest! 